Oxford BioDynamics Plc: Prominent oncologist to discuss advantages of Oxford BioDynamics' EpiSwitch CiRT at the 2022 Liquid Biopsy Virtual Summit
Dr. Steven Mamus, Medical Director of Oncology/Hematology, Cancer Center of Sarasota (FL, US), to present how OBD's EpiSwitch CIRT is transforming the way Immune Checkpoint Inhibitor (ICI) therapy